Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers

BACKGROUND: Fentanyl buccal tablet (FBT; FENTORA®, Cephalon, Inc., Frazer, PA, USA) is indicated in the US for breakthrough pain in patients with cancer who are already receiving and are tolerant to around-the-clock opioid therapy for underlying persistent cancer pain. For each individual patient, F...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Mona, Tempero, Kenneth, Jiang, John G, Simonson, Philip G
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773523/
https://www.ncbi.nlm.nih.gov/pubmed/19915709
http://dx.doi.org/10.1111/j.1753-5174.2008.00009.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773523/
https://www.ncbi.nlm.nih.gov/pubmed/19915709
http://dx.doi.org/10.1111/j.1753-5174.2008.00009.x

Ejemplares similares